Cargando…

Ferroptosis: From Basic Research to Clinical Therapeutics in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the most common and highly heterogeneous malignancies worldwide. Despite the rapid development of multidisciplinary treatment and personalized precision medicine strategies, the overall survival of HCC patients remains poor. The limited survival benefit may b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Ziyue, Xia, Haoming, Cui, Yunfu, Yam, Judy Wai Ping, Xu, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	XIA & HE Publishing Inc. 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647096/ https://www.ncbi.nlm.nih.gov/pubmed/36406319 http://dx.doi.org/10.14218/JCTH.2022.00255

Ejemplares similares

Glucometabolic reprogramming: From trigger to therapeutic target in hepatocellular carcinoma
por: Xia, Haoming, et al.
Publicado: (2022)

The Mechanism and Clinical Significance of Circular RNAs in Hepatocellular Carcinoma
por: Huang, Ziyue, et al.
Publicado: (2021)

Exosomal Non-Coding RNAs: Regulatory and Therapeutic Target of Hepatocellular Carcinoma
por: Xia, Haoming, et al.
Publicado: (2021)

Roles and Molecular Mechanisms of Biomarkers in Hepatocellular Carcinoma with Microvascular Invasion: A Review
por: Zhao, Xudong, et al.
Publicado: (2023)

Research progress of circulating non-coding RNA in diagnosis and treatment of hepatocellular carcinoma
por: You, Junqi, et al.
Publicado: (2023)

Extracellular Vesicles Act as Carriers for Cargo Delivery and Regulate Wnt Signaling in the Hepatocellular Carcinoma Tumor Microenvironment
por: He, Risheng, et al.
Publicado: (2023)

Clathrin light chain A facilitates small extracellular vesicle uptake to promote hepatocellular carcinoma progression
por: Xu, Yi, et al.
Publicado: (2023)

An update on the role of complement in hepatocellular carcinoma
por: Xiao, Zhijie, et al.
Publicado: (2022)

RPNs Levels Are Prognostic and Diagnostic Markers for Hepatocellular Carcinoma
por: Zheng, Wangyang, et al.
Publicado: (2022)

Transcriptional ITPR3 as potential targets and biomarkers for human pancreatic cancer
por: Zheng, Wangyang, et al.
Publicado: (2022)

Mechanisms of Neoantigen-Targeted Induction of Pyroptosis and Ferroptosis: From Basic Research to Clinical Applications
por: Yu, Jie, et al.
Publicado: (2021)

Identify an innovative ferroptosis‐related gene in hepatocellular carcinoma
por: Hu, Gangfeng, et al.
Publicado: (2022)

Clathrin light chain A‐enriched small extracellular vesicles remodel microvascular niche to induce hepatocellular carcinoma metastasis
por: Xu, Yi, et al.
Publicado: (2023)

Editorial: Hepatocellular Carcinoma: From Basic Research to Clinical Trials
por: He, Xing-Xing, et al.
Publicado: (2022)

Redox Modulation and Induction of Ferroptosis as a New Therapeutic Strategy in Hepatocellular Carcinoma
por: Lippmann, Jana, et al.
Publicado: (2020)

Molecular Targets of Ferroptosis in Hepatocellular Carcinoma
por: Liao, Hao, et al.
Publicado: (2021)

The Critical Role of Ferroptosis in Hepatocellular Carcinoma
por: Pan, Fan, et al.
Publicado: (2022)

Integrin-Linked Kinase Overexpression and Its Oncogenic Role in Promoting Tumorigenicity of Hepatocellular Carcinoma
por: Chan, Jenny, et al.
Publicado: (2011)

Perspectives and mechanisms for targeting ferroptosis in the treatment of hepatocellular carcinoma
por: Li, Lanqing, et al.
Publicado: (2022)

From Exosome Biogenesis to Absorption: Key Takeaways for Cancer Research
por: Lau, Nicolas Cheuk Hang, et al.
Publicado: (2023)

The Role of Ferroptosis in the Treatment and Drug Resistance of Hepatocellular Carcinoma
por: Zhao, Siqi, et al.
Publicado: (2022)

GLS2 shapes ferroptosis in hepatocellular carcinoma
por: Suzuki, Sawako, et al.
Publicado: (2023)

SLC27A5 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by downregulating glutathione reductase
por: Xu, Feng-li, et al.
Publicado: (2023)

Computational Identification of Immune- and Ferroptosis-Related LncRNA Signature for Prognosis of Hepatocellular Carcinoma
por: Huang, Anmin, et al.
Publicado: (2021)

G Protein Subunit Gamma 5 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma
por: Wang, Hang, et al.
Publicado: (2022)

Cardiac Aging: From Basic Research to Therapeutics
por: Yan, Mingjing, et al.
Publicado: (2021)

Scutellaria barbata Inhibits Hepatocellular Carcinoma Tumorigenicity by Inducing Ferroptosis of Hepatocellular Carcinoma Cells
por: Li, Yue, et al.
Publicado: (2022)

Tumor-associated Exosomes Are Involved in Hepatocellular Carcinoma Tumorigenesis, Diagnosis, and Treatment
por: Wang, Hang, et al.
Publicado: (2022)

Novel Insights in the Regulatory Mechanisms of Ferroptosis in Hepatocellular Carcinoma
por: Ma, Shiwen, et al.
Publicado: (2022)

New perspectives on ferroptosis and its role in hepatocellular carcinoma
por: Cong, Tianhao, et al.
Publicado: (2022)

The Role of Ferroptosis and Cuproptosis in Curcumin against Hepatocellular Carcinoma
por: Liu, Zhili, et al.
Publicado: (2023)

Uridine Inhibits Hepatocellular Carcinoma Cell Development by Inducing Ferroptosis
por: Zi, Liuliu, et al.
Publicado: (2023)

Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma
por: Liang, Jiaying, et al.
Publicado: (2021)

Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation
por: Bekric, Dino, et al.
Publicado: (2022)

Identification of ferroptosis-related genes for overall survival prediction in hepatocellular carcinoma
por: Luo, Lianxiang, et al.
Publicado: (2022)

Development and validation of four ferroptosis-related gene signatures and their correlations with immune implication in hepatocellular carcinoma
por: Zhang, Ying, et al.
Publicado: (2022)

Establishment and validation of a ferroptosis-related prognostic signature for hepatocellular carcinoma
por: He, Yixian, et al.
Publicado: (2023)

A novel ferroptosis phenotype‐related clinical‐molecular prognostic signature for hepatocellular carcinoma
por: Deng, Tuo, et al.
Publicado: (2021)

Molecular mechanisms of ferroptosis and the potential therapeutic targets of ferroptosis signaling pathways for glioblastoma
por: Zhang, Meng, et al.
Publicado: (2022)

Identification of ferroptosis and drug resistance related hub genes to predict the prognosis in Hepatocellular Carcinoma
por: Li, Chengjun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i45n1v6hrsl8e2tid48rg20tpk